Sort
85,873 grants matching “alzheimers”
Innate Immunity Stimulation Effects on Biomarkers, Cognition, and the Vascular Amyloid Proteome in a Squirrel Monkey Model of Sporadic CAA
$841,182Henrieta Scholtzova · New York University School Of Medicine · R01 · FY2022 · NS
Neuroprotective And Neurorestorative Signaling Mechanisms
$841,141Mark Mattson · National Institute On Aging · ZIA · FY2016 · AG
Ventricular-vascular coupling in the elderly: lifecourse determinants, trajectories and prognostic significance
$841,114Vasan S. Ramachandran · Boston University Medical Campus · R01 · FY2019 · HL
CLINICAL CORE
$841,104Richard J. Caselli · Banner Sun Health Research Institute · P30 · FY2008 · AG
Age-associated cognitive changes in community dwelling adults
$841,103Alan B Zonderman · National Institute On Aging · ZIA · FY2017 · AG
Characterizing Family Structure, Care Utilization, and Well-Being among Persons with ADRD in the Asian Region
$840,931Hanzhang Xu · Duke University · R01 · FY2025 · AG
Data Management and Statistical Core
$840,791Walter K. Kremers · Mayo Clinic Rochester · U19 · FY2021 · AG
Data Management and Statistical Core
$840,790Walter K. Kremers · Mayo Clinic Rochester · U19 · FY2023 · AG
Data Management and Statistical Core
$840,790Walter K. Kremers · Mayo Clinic Rochester · U19 · FY2020 · AG
Data Management and Statistical Core
$840,790Walter K. Kremers · Mayo Clinic Rochester · U19 · FY2024 · AG
Characterization of protective roles of ApoE2 against aging and Alzheimer's disease
$840,770Dongming Cai · Icahn School Of Medicine At Mount Sinai · R56 · FY2019 · AG
An eHealth platform to facilitate financial understanding and legal preparation for patients with dementia and their caregivers
$840,726David Farrell · People Designs, Inc. · R44 · FY2023 · AG
Structures and reagents of NMDA receptors
$840,682Hiroyasu Furukawa · Cold Spring Harbor Laboratory · R01 · FY2023 · MH
Structures and reagents of NMDA receptors
$840,682Hiroyasu Furukawa · Cold Spring Harbor Laboratory · R01 · FY2024 · MH
Structures and reagents of NMDA receptors
$840,682Hiroyasu Furukawa · Cold Spring Harbor Laboratory · R01 · FY2025 · MH
Defining chromostasis - a candidate regulator of healthy aging and longevity
$840,622Peter D. Adams · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2022 · AG
Rates and mechanisms of age-related somatic mutation in normal and Alzheimer brain
$840,497Christopher A Walsh · Boston Children'S Hospital · R01 · FY2024 · AG
Dedicated Brain PET Device Optimized for Brain Imaging
$840,435David M Beylin · Brain Bio · R44 · FY2016 · MH
Optimization and Validation of an Indicator Cell Assay for Blood-Based Diagnosis of Alzheimers Disease
$840,407Jennifer Joy Smith · Precyte, Inc. · R44 · FY2016 · AG
Alpha-Synuclein Induced Network Hyperexcitability in Lewy Body Dementias
$840,282Keith Alan Vossel · University Of California Los Angeles · R56 · FY2021 · AG
Tracking autobiographical thoughts: a smartphone-based approach to identifying cognitive correlates of Alzheimer's disease biomarkers and risk factors in clinically normal older adults
$840,230Matthew D Grilli · University Of Arizona · R01 · FY2023 · AG
Preclinical drug development of isoform selective JNK3 inhibitors for Alzheimer's disease.
$840,205Sung Ok Yoon · Ohio State University · R01 · FY2018 · AG
Pericyte control of capillary perfusion in the Alzheimer's disease brain
$840,133Andy Y Shih · Seattle Children'S Hospital · R01 · FY2024 · AG
Clinical Core
$840,069Teresa Gomez-Isla · Massachusetts General Hospital · P30 · FY2021 · AG
Leptin as a Therapy for Alzheimer's Disease
$840,000Nikolaos Tezapsidis · Neurotez, Inc. · R44 · FY2009 · AG